https://doi.org/10.1002/cpt.907
S
Sisi Qin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.3K
Citations
18
h-index
30
i10-index
Sisi Qin is an academic researcher from University of Chicago. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Estrogen and related hormone effects & Cancer, Lipids, and Metabolism. The author has an h-index of 18, co-authored 68 publications.
ORCID: 0000-0002-1817-9470Papers by this author
worksTSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer
2017 · Clinical Pharmacology & Therapeutics · 40 citations
The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer
2019 · Cancer & Metabolism · 21 citations
https://doi.org/10.1186/s40170-018-0193-4
Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
2018 · Drug Metabolism and Disposition · 14 citations
https://doi.org/10.1124/dmd.118.082164
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
2021 · npj Breast Cancer · 11 citations
https://doi.org/10.1038/s41523-021-00285-x
Cytochrome P450 Transcriptional Regulation by Testis-Specific Y-Encoded-Like Protein: Identification of Novel Upstream Transcription Factors
2022 · Drug Metabolism and Disposition · 4 citations
https://doi.org/10.1124/dmd.122.000945
Metadata record for the manuscript: Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
2021 · Figshare · 1 citations
https://doi.org/10.6084/m9.figshare.14035853
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat